Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-28

FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s abacavir and lamivudine as a generic fixed-dose combination tablet for the treatment of HIV-1 infection in combination antiretrovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)